140 related articles for article (PubMed ID: 21511746)
1. Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma.
Thavendiranathan P; Verhaert D; Kendra KL; Raman SV
Br J Radiol; 2011 May; 84(1001):e99-e102. PubMed ID: 21511746
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis.
Ingkanisorn WP; Paterson DI; Calvo KR; Rosing DR; Schwartzentruber DJ; Fuisz AR; Arai AE
J Cardiovasc Magn Reson; 2006; 8(2):353-60. PubMed ID: 16669178
[TBL] [Abstract][Full Text] [Related]
3. Case report and brief review: IL-2-induced myocarditis.
Eisner RM; Husain A; Clark JI
Cancer Invest; 2004; 22(3):401-4. PubMed ID: 15493361
[TBL] [Abstract][Full Text] [Related]
4. A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.
Guo CW; Alexander M; Dib Y; Lau PKH; Weppler AM; Au-Yeung G; Lee B; Khoo C; Mooney D; Joshi SB; Creati L; Sandhu S
Eur J Cancer; 2020 Jan; 124():15-24. PubMed ID: 31707280
[TBL] [Abstract][Full Text] [Related]
5. Severe myocarditis following high-dose interleukin-2 administration.
Samlowski WE; Ward JH; Craven CM; Freedman RA
Arch Pathol Lab Med; 1989 Aug; 113(8):838-41. PubMed ID: 2787976
[TBL] [Abstract][Full Text] [Related]
6. Acute heart failure as a result of granulomatous myocarditis: case report on a patient with metastatic melanoma treated with dabrafenib and trametinib.
Winkler JK; Buder-Bakhaya K; Ellert E; Herpel E; Martens UM; Enk A; Hassel JC
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e31-e32. PubMed ID: 28695986
[No Abstract] [Full Text] [Related]
7. Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancer.
Kragel AH; Travis WD; Steis RG; Rosenberg SA; Roberts WC
Cancer; 1990 Oct; 66(7):1513-6. PubMed ID: 2208002
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.
Abdel-Aty H; Boyé P; Zagrosek A; Wassmuth R; Kumar A; Messroghli D; Bock P; Dietz R; Friedrich MG; Schulz-Menger J
J Am Coll Cardiol; 2005 Jun; 45(11):1815-22. PubMed ID: 15936612
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in T1 and T2 Mapping in the Assessment of Fulminant Myocarditis by Cardiac Magnetic Resonance.
Wheen P; Armstrong R; Daly CA
Curr Cardiol Rep; 2020 May; 22(7):47. PubMed ID: 32472218
[TBL] [Abstract][Full Text] [Related]
10. High-dose interleukin 2-induced myocarditis: can myocardial damage reversibility be assessed by cardiac MRI?
Chow S; Cove-Smith L; Schmitt M; Hawkins R
J Immunother; 2014 Jun; 37(5):304-8. PubMed ID: 24810642
[TBL] [Abstract][Full Text] [Related]
11. Myocarditis with fulminant type 1 diabetes mellitus diagnosed by cardiovascular magnetic resonance imaging: a case report.
Makino K; Nishimae I; Suzuki N; Nitta S; Saitoh H; Kasao M; Takazawa K
BMC Res Notes; 2013 Sep; 6():347. PubMed ID: 24060110
[TBL] [Abstract][Full Text] [Related]
12. Fulminant adrenergic myocarditis complicated by pulmonary edema, cardiogenic shock and cardiac arrest.
Rostoff P; Nessler B; Pikul P; Golinska-Grzybala K; Miszalski-Jamka T; Nessler J
Am J Emerg Med; 2018 Feb; 36(2):344.e1-344.e4. PubMed ID: 29146416
[TBL] [Abstract][Full Text] [Related]
13. Syndrome of inappropriate antidiuretic hormone secretion caused by high-dose bolus interleukin-2 therapy for metastatic melanoma.
Green MR; Woolery JE; Elquza E
Am J Ther; 2011 Sep; 18(5):e159-61. PubMed ID: 20592664
[TBL] [Abstract][Full Text] [Related]
14. High-dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma.
Dutcher J
Oncology (Williston Park); 2002 Nov; 16(11 Suppl 13):3. PubMed ID: 12469933
[No Abstract] [Full Text] [Related]
15. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract][Full Text] [Related]
16. Tissue Characterization by Mapping and Strain Cardiac MRI to Evaluate Myocardial Inflammation in Fulminant Myocarditis.
Li H; Zhu H; Yang Z; Tang D; Huang L; Xia L
J Magn Reson Imaging; 2020 Sep; 52(3):930-938. PubMed ID: 32080960
[TBL] [Abstract][Full Text] [Related]
17. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor-induced myocarditis not visible with cardiac magnetic resonance imaging but detected with PET-CT: a case report.
Arponen O; Skyttä T
Acta Oncol; 2020 Apr; 59(4):490-492. PubMed ID: 31920130
[No Abstract] [Full Text] [Related]
19. [Value of cardiovascular magnetic resonance in acute myocarditis].
Wein M; Banach R; Wolf-Pütz A; Skutta B; Strauer BE; Klein RM
Dtsch Med Wochenschr; 2008 Jan; 133(3):87-91. PubMed ID: 18186011
[TBL] [Abstract][Full Text] [Related]
20. High-dose interleukin-2 in patients with metastatic melanoma whose disease progressed after biochemotherapy.
Buzaid AC; Schmerling RA; Vieira Guedes RA; de Freitas D; William WN
Melanoma Res; 2011 Aug; 21(4):370-5. PubMed ID: 21558968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
